1. Home
  2. NGVT vs NNNN Comparison

NGVT vs NNNN Comparison

Compare NGVT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • NNNN
  • Stock Information
  • Founded
  • NGVT 1964
  • NNNN 2021
  • Country
  • NGVT United States
  • NNNN Germany
  • Employees
  • NGVT N/A
  • NNNN N/A
  • Industry
  • NGVT Major Chemicals
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • NGVT Industrials
  • NNNN Health Care
  • Exchange
  • NGVT Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • NGVT 2.1B
  • NNNN 2.2B
  • IPO Year
  • NGVT N/A
  • NNNN 2025
  • Fundamental
  • Price
  • NGVT $58.13
  • NNNN $43.18
  • Analyst Decision
  • NGVT Buy
  • NNNN
  • Analyst Count
  • NGVT 2
  • NNNN 0
  • Target Price
  • NGVT $58.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • NGVT 266.6K
  • NNNN 60.9K
  • Earning Date
  • NGVT 10-28-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • NGVT N/A
  • NNNN N/A
  • EPS Growth
  • NGVT N/A
  • NNNN N/A
  • EPS
  • NGVT N/A
  • NNNN 0.06
  • Revenue
  • NGVT $1,324,800,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • NGVT N/A
  • NNNN N/A
  • Revenue Next Year
  • NGVT $5.18
  • NNNN N/A
  • P/E Ratio
  • NGVT N/A
  • NNNN $780.77
  • Revenue Growth
  • NGVT N/A
  • NNNN 21.95
  • 52 Week Low
  • NGVT $28.49
  • NNNN $5.18
  • 52 Week High
  • NGVT $60.77
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 59.21
  • NNNN N/A
  • Support Level
  • NGVT $56.99
  • NNNN N/A
  • Resistance Level
  • NGVT $60.77
  • NNNN N/A
  • Average True Range (ATR)
  • NGVT 1.48
  • NNNN 0.00
  • MACD
  • NGVT -0.39
  • NNNN 0.00
  • Stochastic Oscillator
  • NGVT 42.73
  • NNNN 0.00

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: